Table 2.
Histology results for newly detected lesions by CEM (n = 33)
| Parameter | Value |
|---|---|
| Benign (n = 15 from 13 patients) | |
| Histology | |
| Fibrocystic change, sclerosing adenosis, stromal fibrosis | 8/15 (53.3%) |
| Fibroadenoma | 5/15 (33.3%) |
| Papilloma | 1/15 (6.7%) |
| Radial scar | 1/15 (6.7%) |
| Biopsy modality for benign lesions | |
| Ultrasound guided | 11/15 (73.3%) |
| MRI guided | 4/15 (26.7%) |
| Malignant (n = 18 for 12 patients) | |
| Histology | |
| Invasive ductal carcinoma | 11/18 (61.1%) |
| Invasive lobular carcinoma | 6/18 (33.3%) |
| Ductal carcinoma in situ | 1/18 (5.6%) |
| Biopsy modality for malignant lesions | |
| Ultrasound guided | 17/18 (94.4%) |
| MRI guided | 1/18 (5.6%) |